Elex Media licenses debut novel The Promised Neverland – News

1st Norman-centric novel debuted in 2018

Indonesian publisher Elex Media Komputindo’s official Twitter account announced last week that it had granted a license Yakusoku no Neverland: Norman kara no Tegami (The Promised Neverland: A Letter from Norman), the first novel based on Kaiu Shirai and Posuka demizu‘s The promised imaginary land (Yakusoku no Neverland) manga.

The novel centers on (highlight white text to read spoilers) Norman’s memories of Emma and the other children of Grace Field House as he wrote them his letter the day he left. The novel was shipped to Japan in June 2018. Nanao wrote the four novels of the franchise.

The second novel, Yakusoku no Neverland: Mama-tachi no Tsuisōkyoku (The Promised Neverland: Moms’ Song of Remembrance), published in January 2019. The second novel focuses on Isabella and Sister Krone. The third novel, Yakusoku no Neverland: Senyū-tachi no recording (The Promised Neverland: Record of War Buddies), ships October 2020. The novel focuses on Yuugo and Lucas. The fourth novel, Yaksoku no Neverland: Omoide no Film-tachi (The Promised Neverland: The Films of Memories), ships December 2020.

Shiraï and Posuka demizu spear The promised imaginary land in Shueisha‘s Weekly Shonen Jump magazine in August 2016 and finished it in June 2019. Elex Media publishes the manga in Indonesia.

The first anime adaptation premiered in January 2019. Aniplus-Asia broadcast a simultaneous broadcast anime in Southeast Asia. A second season of the anime premiered on January 8. Aniplus-Asia also broadcast a simultaneous broadcast for the animated.

A live-action film adaptation of the manga opened in December 2019. Amazon is developing a separate English adaptation of a live-action series of the manga.

Source: Twitter of Elex Media Account via Kaori Nusantara

Source link

About Karren Campbell

Check Also

Study Proves Safety and Effectiveness of New Radionuclide Therapy for Neuroendocrine Neoplasms

A new type of peptide receptor radionuclide therapy (PRRT) has been shown to control disease …